I-131 Patient Release Dose Calculation Principles & Recent Research Lynn McGuire, MS, DABMP Consultant Medical Physicist (ret) UAMS Department of Radiology.

Slides:



Advertisements
Similar presentations
Computer Simulation for Emission Tomography: Geant4 and GATE Xiao Han Aug
Advertisements

Iodine-131 Therapy and the Dialysis Patient M.J. Bohan and R.L. Richardson Yale-New Haven Hospital Radiation Safety Office.
NE Introduction to Nuclear Science Spring 2012 Classroom Session 9: Radiation Interaction with Matter  Absorbed Dose (D), Kerma (K) Gray (Gy) =
WSC Radioecology Research Group A new methodology for the assessment of radiation doses to biota under non-equilibrium conditions J. Vives i Batlle, R.C.
Frank P. Dawry.
Radiation Safety Engineering, Inc Shielding Design for PET Clinics Robert L. Metzger, Ph.D.
Energy deposition and neutron background studies for a low energy proton therapy facility Roxana Rata*, Roger Barlow* * International Institute for Accelerator.
Release of Patients Treated with I-131: An Update Michael Fuller Team Leader Medical Radiation Safety Team U.S. NRC.
1 Development of an FDA CT Organ Dose Handbook Thalia T. Mills, Ph. D. FDA Commissioner’s Fellowship project with Dr. Stanley.
Algorithms used in heterogeneous dose calculations show systematic error as measured with the Radiological Physics Center’s anthropomorphic thorax phantom.
Estimation of the effects of a lead vest on dose reduction for NPP workers using Monte Carlo calculations KIM JEONG-IN.
A Complication in Determining the Precise Age of the Solar System Dating early Solar System events by the Pb-Pb method can resolve absolute age differences.
Radiation Safety Oversight of Surgical Procedures Involving the Use of RAM René Michel, M.S., RSO VA San Diego Healthcare System, San Diego, CA.
MIRD Pamphlet No. 21: A Generalized Schema for Radiopharmaceutical Dosimetry—Standardization of Nomenclature 5/15/2009.
Radioactive Drug Research Committee
MONTE CARLO RADIATION DOSE SIMULATIONS AND DOSIMETRY COMPARISON OF THE MODEL 6711 AND I BRACHYTHERAPY SOURCES Mark J. Rivard Department of Radiation.
Tissue inhomogeneities in Monte Carlo treatment planning for proton therapy L. Beaulieu 1, M. Bazalova 2,3, C. Furstoss 4, F. Verhaegen 2,5 (1) Centre.
Radiation Dosimetry Dose Calculations D, LET & H can frequently be obtained reliably by calculations: Alpha & low – Energy Beta Emitters Distributed in.
Alexander Brandl ERHS 630 Effective and Committed Effective Dose Environmental and Radiological Health Sciences.
Radiology is concerned with the application of radiation to the human body for diagnostically and therapeutically purposes. This requires an understanding.
The brachytherapy advanced example Susanna Guatelli (CERN/INFN)
Bruce Thomadsen University of Wisconsin Madison Some Current Regulatory issues from the ACMUI.
DIGITAL HIGH-RESOLUTION HEART PHANTOMS Abstract Background:X-ray based imaging modalities employ ionizing radiation with the potential for causing harmful.
Radiation Dosimetry of the Patient
Étienne Létourneau, Fabiola Vallejo Castaneda, Nancy El Bared, Danny Duplan, Martin Hinse Presented by: Étienne Létourneau 2015 Joint Congress, Montreal,
Applications of Geant4 in Proton Radiotherapy at the University of Texas M.D. Anderson Cancer Center Jerimy C. Polf Assistant Professor Department of Radiation.
Fundamentals of Radiation
G. Bartesaghi, 11° ICATPP, Como, 5-9 October 2009 MONTE CARLO SIMULATIONS ON NEUTRON TRANSPORT AND ABSORBED DOSE IN TISSUE-EQUIVALENT PHANTOMS EXPOSED.
Study of the Halo Nucleus 6 He using the 6 Li(   ) 6 He Reaction Derek Branford - Edinburgh University for the A2-Collaboration MAMI-B Mainz.
VIII.3. Optimization of Protection for Medical Exposures in Nuclear Medicine 2. Dose to patient Postgraduate Educational Course in Radiation Protection.
Need for Internal Dosimetry: Fundamentals to Clinical Practice – and Opportunity to Personalize Cancer Therapy Darrell R. Fisher Pacific Northwest National.
Ye, Sung-Joon, Ph.D. Ove, Roger, M.D., Ph.D.; Shen, Sui, Ph.D.
Basic Survey: External dose estimation Radiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University The International.
Determination of Effective Half-Life of 131 I in Thyroid Cancer Patients Hoang T. Vu Allen Hrejsa & Alex Markovic *Department of Medical Radiation Physics,
Thyroid equivalent doses due to radioiodine(I-131) intake for evacuees caused by the nuclear accident in Fukushima S. Tokonami, M. Hosoda (Hirosaki Univ.)
Evaluation of absorbed fractions for beta- gamma radionuclides in ellipsoidal volumes of soft tissue through Geant4 Ernesto Amato 1, Domenico Lizio 2 and.
Authorization and Inspection of Cyclotron Facilities Design, Layout and Shielding.
Introduction The Radiological Physics Center (RPC) anthropomorphic quality assurance (QA) phantom program is one tool the RPC uses to remotely audit institutions.
Determining Radiation Intensity
A Comparison Between Two Leading Stereotactic Platforms in the Treatment of Multiple Metastases Sandra Vermeulen MD, James Raisis.
Warm-Up #1 11/30 1. Write down these 3 formulas:
Gate-simulation of dose G4: David Nokto & Anette Kniberg.
Comparison of MC and TP Dosimetry Simulations for Cancer Treatment Raymond Mumme May 12, 2014 Supervisor: Thiago Lima (PhD student) Head Supervisor: Dr.
P. Rodrigues, A. Trindade, L.Peralta, J. Varela GEANT4 Medical Applications at LIP GEANT4 Workshop, September – 4 October LIP – Lisbon.
E. DUPONT, J.MARCEL, Q. PIERRE, A. THOMAS, F. PAUL, Hopital DUPONT Service radiologique Vienne RESULTS : Results are presented about two different irradiation.
ESTRO, Geneva 2003 The importance of nuclear interactions for dose calculations in proton therapy M.Soukup 1, M.Fippel 2, F. Nuesslin 2 1 Department of.
U-spin and the Radiative decay of Strange Baryons K. Hicks and D.Keller EM Transition Form Factor Workshop October 13, 2008.
THE RADIATION SAFETY IN A “DAILY LIFE” Introduction Volodymyr Berkovskyy.
한양대학교 원자력공학과 김 찬 형 제44회 춘계의학물리학회 & Geant4 Workshop (충무, 마리나 리조트, ) Monte Carlo 원리 및 응용.
Yair Grof.  Ph.D in Nuclear Physics – LANL, USA  – Head, dosimetry department, NRC – SOREQ  – Sabbatical at NMSU, USA  2009 –
ESTIMATION OF HOSPITAL STAY TIME FOR CA-THYROID PATIENTS TREATED WITH RADIOIODINE-131 By Sudipta Saha 1 Dr. Ashoke kumar paul 2 Dr. M. Shakilur rahman.
Radiation Protection Omar Desouky Review article Submitted by:
Louisiana State University Radiation Safety Office
Date of download: 10/7/2017 Copyright © ASME. All rights reserved.
Induced-activity experiment:
Quantitative Nuclear Medicine Imaging
Very High Energy Electron for Radiotherapy Studies
Summary of the Compton-PET project
A Brachytherapy Treatment Planning Software Based on Monte Carlo Simulations and Artificial Neural Network Algorithm Amir Moghadam.
Arghya Chattaraj, T. Palani Selvam, D. Datta
Modeling Iodine Released During a Nuclear Power Plant Accident
Human Intrusion in Deep Geologic Repositories in the U.S.
Figure 4 Treatment plans using stereotactic body radiotherapy (SBRT)
By: Vi Nhan Nguyen University of Arizona
Geant4 at IST Applications in Brachytherapy
Estimation of the effects of a lead vest on dose reduction for NPP workers using Monte Carlo calculations KIM JEONG-IN.
The External Radiation Hazard
Investigation of a Dynamic Measurement Methodology for Fast Detection
Frequency distributions of (a), (d), (g), (j) & (m) maximum thicknesses and (b), (e), (h), (k) & (n) apparent widths, and (c), (f), (i), (l) & (o) tables.
Presentation transcript:

I-131 Patient Release Dose Calculation Principles & Recent Research Lynn McGuire, MS, DABMP Consultant Medical Physicist (ret) UAMS Department of Radiology

Dose to others from an I-131 patient Dose calculation methods & fundamentals Physical principles, geometry and scenarios More realistic geometries per Young, et al publications

Dose calculation methods & fundamentals Source – Target Physical - T 1/2, decay scheme Geometry Scenarios –Time & distance –Phantoms Biology – kinetics, time course of activity

Isotope physical data T 1/2, decay scheme I-131: 8 da, 364 keV gamma, 80% emission. =.22 1m

Geometries Target Point 3D Source Point 2D – Line 3D (distributed, volume)

Point source geometry

Geometries Target Point 3D Source Point 2D – Line 3D (distributed, volume) Phantoms & patients –Gender –Age –Posture –Activity distribution Disease state

Dosimetry phantoms - early

ORNL stylized

UF/NCI

Exposure Scenarios –Time = Occ. Factor (OF or E) –distance –Phantoms

Exposure Scenarios –Time & distance –Phantoms

I-131 distribution

NOW we can do those pesky dose calcs…

Dosimetry First Principles Physical decay Physical + biological D(∞)= 34.6*D 0 *T p (34.6=24*1.44) D(∞)= 34.6*D 0 *T E (T E =Tp*Tb/(Tp+Tb)

Dosimetry First Principles (2) Physical + biological w/occup factor E NRC case, App U-2 D(∞)= 34.6*D 0 *T E *E D= 34.6*.22*33mCi*8da*1/4=500 mrem

Physical decay only, with E (occ factor) 34.6

Time-activity or Retention curve

MIRD dosimetry Teff

NUREG 1556 App U, eq B-5

Regulatory reqt.

NUREG-1556 assumes point target, source

Han et al publications

All pubs posted at elmmhp.wordpress.com

Han, et al publications PhD research UF UF/NCI phantom family MCNP code code for photon transport Dose as TEDE Develop s-factors for multiple scenarios Use NRC uptake& retention model Provides mSv/ (mR/h) values Suggested time restrictions

Han exposure scenarios Phantom – age/gender Orientation – Facing; side to side; holding (infants) Hyperthyroidism & cancer – activity distribution

(MCNP) Monte carlo

RPD paper

MP paper: S-factors, hyper & organ doses

8x-80x greater 2x-20x greater

Fraction of adult TEDE Tables 2 & 3, Han et al, JRP cm 100 cm 200 cm HyperDTCHyperDTCHyperDTC 1 yo.11E-21.8E-26.7E-210E-212E-2 5 yo7E-254E-279E-298E-2100E-2

Takeaways NRC point source method conservative Han et al -<1/2 NRC, implies thy ca discharge OK ~400 mCi -S-factors given for non standard or default cases -Dose with age -Distance: dose similar to point sources >1 m, <1 m

Future refinements? REAL patient specific data – Biodistribution – SPECT/PET/CT Useful for more precise patient treatment/dose Necessary for patient release?